LY-2452473 Completed Phase 2 Trials for Prostate Cancer Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive Care2
clinicaltrials.gov IdentifierTitleDrugs
NCT02499497A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer